Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rangering i aksjer #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Aksjekurs
$0.0045
Sist synkronisert: 2026-08-13
Markedsverdi
$591.52K
Endring (1 dag)
-10.00%
Endring (1 år)
-86.76%
Land
US
Handel Burzynski Research Institute, Inc. (BZYR)

Kategori

P/B-forhold for Burzynski Research Institute, Inc. (BZYR)
P/B-forhold per 2026 TTM: 0
Ifølge Burzynski Research Institute, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Burzynski Research Institute, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter